Deep Track Capital, LP

GREENWICH, CT · CIK 1856083 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$6.8bn reported value +40.1% vs Q1 2026

66positions

40.1%in top 10

18 new 22 added 15 reduced 14 sold out vs Q1 2026

Options: 1 call positions ($82.4m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	GUARDANT HEALTH INC COM GH	GH	3,393,312	$509.1m7.50%	7.50%	Added +55.1k	+55,071 1.6%
2	IMMUNOVANT INC COM IMVT	IMVT	9,341,151	$359.9m5.30%	5.30%	Reduced -2.2m	-2,185,820 -19.0%
3	STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR	GPCR	4,740,072	$254.4m3.75%	3.75%	Added +460.2k	+460,224 10.8%
4	VAXCYTE INC COM PCVX	PCVX	4,300,000	$250.0m3.68%	3.68%	Unchanged
5	ALNYLAM PHARMACEUTICALS INC COM ALNY	ALNY	825,000	$248.3m3.66%	3.66%	New
6	VERADERMICS INC COMMON STOCK MANE	MANE	2,000,000	$245.9m3.62%	3.62%	Added +1.5m	+1,500,000 300.0%
7	TARSUS PHARMACEUTICALS INC COM TARS	TARS	3,666,768	$230.8m3.40%	3.40%	Added +66.8k	+66,768 1.9%
8	NUVALENT INC COM COM		1,783,322	$220.2m3.24%	3.24%	Added +407.0k	+406,998 29.6%
9	ALKERMES PLC SHS ALKS	ALKS	4,000,000	$209.6m3.09%	3.09%	Added +409.7k	+409,677 11.4%
10	OCULAR THERAPEUTIX INC COM OCUL	OCUL	19,686,282	$193.3m2.85%	2.85%	Unchanged
11	BIOMARIN PHARMACEUTICAL INC COM BMRN	BMRN	3,307,481	$189.3m2.79%	2.79%	Added +2.2m	+2,157,481 187.6%
12	NURIX THERAPEUTICS INC COM NRIX	NRIX	7,736,455	$187.7m2.76%	2.76%	Added +1.4m	+1,391,211 21.9%
13	ORUKA THERAPEUTICS INC COM ORKA	ORKA	1,926,000	$183.3m2.70%	2.70%	Reduced -108.2k	-108,203 -5.3%
14	ALUMIS INC COM ALMS	ALMS	6,348,558	$178.6m2.63%	2.63%	Reduced -424.0k	-424,037 -6.3%
15	IONIS PHARMACEUTICALS INC COM IONS	IONS	2,200,000	$174.4m2.57%	2.57%	Added +250.0k	+250,000 12.8%
16	COMPASS PATHWAYS PLC SPONSORED ADS CMPS	CMPS	12,161,496	$172.1m2.54%	2.54%	Unchanged
17	VERA THERAPEUTICS INC CL A VERA	VERA	4,000,000	$171.6m2.53%	2.53%	Reduced -106.1k	-106,067 -2.6%
18	AXSOME THERAPEUTICS INC COM AXSM	AXSM	700,000	$171.3m2.52%	2.52%	Reduced -400.0k	-400,000 -36.4%
19	GENMAB A/S SPONSORED ADS GMAB	GMAB	5,650,000	$155.2m2.29%	2.29%	Added +2.0m	+1,986,750 54.2%
20	MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX	MLTX	6,999,025	$136.3m2.01%	2.01%	Added +590.2k	+590,162 9.2%
21	HEMAB THERAPEUTICS HLDGS INC COM SHS COAG	COAG	3,602,093	$132.3m1.95%	1.95%	New
22	TANGO THERAPEUTICS INC COM TNGX	TNGX	4,200,000	$131.3m1.93%	1.93%	Added +1.4m	+1,450,000 52.7%
23	DEFINIUM THERAPEUTICS INC COM SHS DFTX	DFTX	2,750,000	$129.4m1.91%	1.91%	Reduced -250.0k	-250,000 -8.3%
24	GRAIL INC COM GRAL	GRAL	1,834,944	$125.3m1.85%	1.85%	Added +112.1k	+112,147 6.5%
25	BICARA THERAPEUTICS INC COM BCAX	BCAX	4,100,000	$121.7m1.79%	1.79%	Added +37.5k	+37,500 0.9%
26	MAZE THERAPEUTICS INC COM MAZE	MAZE	3,732,569	$111.4m1.64%	1.64%	Added +255.0k	+255,007 7.3%
27	CELLDEX THERAPEUTICS INC NEW COM NEW CLDX	CLDX	2,939,151	$109.4m1.61%	1.61%	Added +1.7m	+1,655,172 128.9%
28	LB PHARMACEUTICALS INC COM SHS LBRX	LBRX	3,352,804	$108.8m1.60%	1.60%	Unchanged
29	MBX BIOSCIENCES INC COM MBX	MBX	1,732,569	$95.6m1.41%	1.41%	Reduced -1.0m	-1,025,000 -37.2%
30	GH RESEARCH PLC ORDINARY SHARES GHRS	GHRS	3,333,334	$89.6m1.32%	1.32%	New
31	COGENT BIOSCIENCES INC COM COGT	COGT	2,000,000	$77.4m1.14%	1.14%	Added +1.0m	+1,000,000 100.0%
32	ATAIBECKLEY INC COM SHS ATAI	ATAI	14,417,442	$76.0m1.12%	1.12%	Added +2.4m	+2,417,442 20.1%
33	UNITED THERAPEUTICS CORP DEL COM UTHR	UTHR	123,616	$67.0m0.99%	0.99%	New
34	AVALO THERAPEUTICS INC COM NEW AVTX	AVTX	3,610,000	$66.7m0.98%	0.98%	New
35	VIRIDIAN THERAPEUTICS INC COM VRDN	VRDN	3,592,740	$66.0m0.97%	0.97%	Added +2.2m	+2,198,796 157.7%
36	CYTOKINETICS INC COM NEW CYTK	CYTK	700,000	$59.6m0.88%	0.88%	Reduced -674.3k	-674,320 -49.1%
37	ALTIMMUNE INC COM NEW ALT	ALT	19,250,000	$58.5m0.86%	0.86%	New
38	PERSONALIS INC COM PSNL	PSNL	4,000,000	$53.6m0.79%	0.79%	Added +1.0m	+1,000,000 33.3%
39	ACLARIS THERAPEUTICS INC COM ACRS	ACRS	9,345,000	$49.4m0.73%	0.73%	Unchanged
40	CORMEDIX INC COM CRMD	CRMD	6,274,076	$49.3m0.73%	0.73%	Unchanged
41	GENEDX HOLDINGS CORP COM CL A WGS	WGS	700,000	$48.1m0.71%	0.71%	New
42	HARROW INC COM HROW	HROW	969,000	$41.2m0.61%	0.61%	New
43	CORVUS PHARMACEUTICALS INC COM CRVS	CRVS	2,491,939	$37.2m0.55%	0.55%	Added +400	+400 0.0%
44	SOLID BIOSCIENCES INC COM NEW SLDB	SLDB	3,565,062	$35.6m0.52%	0.52%	Unchanged
45	BEAM THERAPEUTICS INC COM BEAM	BEAM	1,000,000	$34.3m0.51%	0.51%	Added +179.2k	+179,235 21.8%
46	DYNE THERAPEUTICS INC COM DYN	DYN	1,500,000	$33.3m0.49%	0.49%	Reduced -500.0k	-500,000 -25.0%
47	IMMIX BIOPHARMA INC COM IMMX	IMMX	2,775,000	$28.6m0.42%	0.42%	New
48	X4 PHARMACEUTICALS INC COM NEW XFOR	XFOR	5,878,757	$27.5m0.40%	0.40%	Reduced -460.8k	-460,778 -7.3%
49	SHATTUCK LABS INC COM STTK	STTK	3,706,734	$25.7m0.38%	0.38%	New
50	MANNKIND CORP COM NEW MNKD	MNKD	6,000,000	$25.6m0.38%	0.38%	New
51	CENTURY THERAPEUTICS INC COM IPSC	IPSC	9,462,645	$23.2m0.34%	0.34%	Reduced -25.1k	-25,100 -0.3%
52	GENERATE BIOMEDICINES INC COM SHS GENB	GENB	1,333,815	$22.5m0.33%	0.33%	New
53	VERASTEM INC COM NEW VSTM	VSTM	5,740,850	$21.9m0.32%	0.32%	Unchanged
54	KURA ONCOLOGY INC COM KURA	KURA	1,978,565	$21.7m0.32%	0.32%	Reduced -665.0k	-664,977 -25.1%
55	ENANTA PHARMACEUTICALS INC COM ENTA	ENTA	1,444,167	$21.1m0.31%	0.31%	Reduced -512.7k	-512,700 -26.2%
56	NEKTAR THERAPEUTICS COM NEW NKTR	NKTR	300,000	$20.9m0.31%	0.31%	New
57	OLEMA PHARMACEUTICALS INC COM OLMA	OLMA	1,500,000	$18.8m0.28%	0.28%	New
58	KAILERA THERAPEUTICS INC COMMON STOCK KLRA	KLRA	700,000	$15.4m0.23%	0.23%	New
59	KARDIGAN INC COM KARD	KARD	600,000	$14.3m0.21%	0.21%	New
60	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	225,000	$11.4m0.17%	0.17%	New
61	PROMIS NEUROSCIENCES INC COM SHS PMN	PMN	835,655	$11.0m0.16%	0.16%	Unchanged
62	IMMUNOCORE HLDGS PLC ADS IMCR	IMCR	311,218	$9.9m0.15%	0.15%	Reduced -1.6m	-1,620,666 -83.9%
63	XENCOR INC COM XNCR	XNCR	593,551	$9.6m0.14%	0.14%	New
64	CONTEXT THERAPEUTICS INC COM CNTX	CNTX	7,419,355	$4.1m0.06%	0.06%	Unchanged
65	INVENTIVA SA ADS IVA	IVA	800,000	$3.0m0.04%	0.04%	Reduced -422.5k	-422,453 -34.6%
66	ALIGOS THERAPEUTICS INC COM NEW ALGS	ALGS	444,110	$2.6m0.04%	0.04%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
APELLIS PHARMACEUTICALS INC APLS	APLS	4,532,374	$182.3m4.5m shares
CENTESSA PHARMACEUTICALS PLC		3,158,041	$125.4m3.2m shares
BRIDGEBIO PHARMA INC BBIO	BBIO	841,445	$62.5m841.4k shares
TERNS PHARMACEUTICALS INC		1,073,877	$56.6m1.1m shares
GERON CORP GERN	GERN	31,720,278	$47.3m31.7m shares
ANI PHARMACEUTICALS INC ANIP	ANIP	600,000	$46.1m600.0k shares
SOLENO THERAPEUTICS INC SLNO	SLNO	1,078,710	$36.1m1.1m shares
ENGENE HOLDINGS INC		4,377,572	$29.8m4.4m shares
APOGEE THERAPEUTICS INC		285,000	$24.0m285.0k shares
JANUX THERAPEUTICS INC JANX	JANX	1,187,290	$16.5m1.2m shares
CRESCENT BIOPHARMA INC. CBIO	CBIO	453,686	$8.3m453.7k shares
LARIMAR THERAPEUTICS INC LRMR	LRMR	1,500,000	$6.8m1.5m shares
CYBIN INC		1,313,137	$6.3m1.3m shares
BILLIONTOONE INC BLLN	BLLN	50,000	$3.9m50.0k shares

Options (notional value)

Underlying	Ticker	Type	Shares controlled	Notional	Change
GENMAB A/S GMAB · Call	GMAB	Call	3,000,000	$82.4m3.0m shares	New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 27.

Company	Ticker	Stake	Change	Schedule	Last filed
LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10	LBRX	11.7%≈ $108.8m	-3.2 pts	13D	2026-02-10
ALTIMMUNE INC ALT · 13G · filed 2026-04-30	ALT	10.0%≈ $59.0m	new	13G	2026-04-30
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06	PMN	10.0%≈ $11.9m	new	13G	2026-02-06
VERASTEM INC VSTM · 13G · filed 2025-11-21	VSTM	10.0%≈ $29.5m	new	13G	2025-11-21
COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17	CMPS	10.0%	new	13G	2025-01-17
RAPT THERAPEUTICS INC 13G · filed 2024-12-23		9.9%	new	13G	2024-12-23
MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14	MLTX	9.7%≈ $155.7m	+3.3 pts	13G	2026-08-14
OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15	OCUL	9.5%≈ $204.7m	+4.4 pts	13G	2026-05-15
MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14	MAZE	9.0%≈ $117.8m	+2.1 pts	13G	2025-08-14
IMMUNIC INC 13G · filed 2026-03-04		8.7%	new	13G	2026-03-04
ALECTOR INC ALEC · 13G · filed 2026-10-23	ALEC	8.6%≈ $21.3m	new	13G	2026-10-23
TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15	TARS	8.5%≈ $226.6m	+1.4 pts	13G	2026-05-15
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14	XFOR	8.3%≈ $37.6m	-1.7 pts	13G	2026-08-14
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15	CNTX	8.3%≈ $4.1m		13G	2025-05-15
HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08	COAG	8.2%≈ $132.3m	new	13G	2026-05-08
CORMEDIX INC CRMD · 13G · filed 2026-05-15	CRMD	7.9%≈ $49.3m	+1.7 pts	13G	2026-05-15
NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14	NRIX	7.5%≈ $187.7m	+1.3 pts	13G	2026-08-14
CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15	IPSC	7.3%≈ $33.0m	new	13G	2026-01-15
ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17	ACRS	7.0%≈ $49.4m	new	13G	2026-03-17
AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14	AVTX	6.9%≈ $66.7m	+1.1 pts	13G	2026-08-14
MIND MEDICINE MINDMED INC 13G · filed 2025-11-14		6.9%	-1.3 pts	13G	2025-11-14
ENGENE HOLDINGS INC 13G · filed 2025-11-18		6.7%	+2.3 pts	13G	2025-11-18
BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15	BCAX	6.2%≈ $120.6m	+1.2 pts	13G	2026-05-15
ALUMIS INC ALMS · 13G · filed 2026-04-07	ALMS	6.0%≈ $207.2m	new	13G	2026-04-07
STRUCTURE THERAPEUTICS INC GPCR · 13G · filed 2026-02-13	GPCR	6.0%	-1.4 pts	13G	2026-02-13